Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 156-162

  Meuleman, Philip ^a   Steyaert, Sophia ^a   Libbrecht, Louis ^b   Couvent, Sibyl ^a   Van Houtte, Freya ^a   Clinckspoor, Filip ^a   De Hemptinne, Bernard ^c   Roskams, Tania ^b   Vanlandschoot, Peter ^a   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

CD14; Endotoxemia; Hepatitis B; Hepatitis C; Human hepatocyte; uPA SCID

Indexed keywords

CD14 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD14; BLOTTING, WESTERN; CELL TRANSPLANTATION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INBREEDING; MALE; MICE; MICE, INBRED NOD; MICE, INBRED STRAINS; MICE, SCID; MICE, TRANSGENIC; SOLUBILITY; TRANSPLANTATION, HETEROLOGOUS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33644663401     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.09.022     Document Type: Article

References (48)

1. R.J. Ulevitch, and P.S. Tobias Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin Annu Rev Immunol 13 1995 437 457
2. A. Haziot, S. Chen, E. Ferrero, M.G. Low, R. Silber, and S.M. Goyert The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage J Immunol 141 1988 547 552
3. B. Beutler Tlr4: central component of the sole mammalian LPS sensor Curr Opin Immunol 12 2000 20 26
4. A. Devitt, O.D. Moffatt, C. Raykundalia, J.D. Capra, D.L. Simmons, and C.D. Gregory Human CD14 mediates recognition and phagocytosis of apoptotic cells Nature 392 1998 505 509
5. U. Grunwald, X. Fan, and R.S. Jack Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism J Immunol 157 1996 4119 4125
6. D. Iwaki, H. Mitsuzawa, and S. Murakami The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus J Biol Chem 277 2002 24315 24320
7. D. Iwaki, C. Nishitani, H. Mitsuzawa, N. Hyakushima, H. Sano, and Y. Kuroki The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain Biochem Biophys Res Commun 328 2005 173 176
8. H. Beekhuizen, I. Blokland, A.J. Corsel-van Tilburg, F. Koning, and R. van Furth CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells J Immunol 147 1991 3761 3767
9. P. Vanlandschoot, F. Van Houtte, and A. Roobrouck LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles J Gen Virol 83 2002 2279 2289
10. C. Fearns, V.V. Kravchenko, R.J. Ulevitch, and D.J. Loskutoff Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide J Exp Med 181 1995 857 866
11. S. Liu, L.S. Khemlani, and R.A. Shapiro Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia Infect Immun 66 1998 5089 5098
12. Y. Vodovotz, S. Liu, C. McCloskey, R. Shapiro, A. Green, and T.R. Billiar The hepatocyte as a microbial product-responsive cell J Endotoxin Res 7 2001 365 373
13. S.W. Li, J.P. Gong, C.X. Wu, Y.J. Shi, and C.A. Liu Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia World J Gastroenterol 8 2002 124 127
14. V. Bazil, and J.L. Strominger Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes J Immunol 147 1991 1567 1574
15. P. Bufler, G. Stiegler, and M. Schuchmann Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants Eur J Immunol 25 1995 604 610
16. G.L. Su, K. Dorko, S.C. Strom, A.K. Nussler, and S.C. Wang CD14 expression and production by human hepatocytes J Hepatol 31 1999 435 442
17. S. Bas, B.R. Gauthier, U. Spenato, S. Stingelin, and C. Gabay CD14 is an acute-phase protein J Immunol 172 2004 4470 4479
18. C.J. Hetherington, P.D. Kingsley, and F. Crocicchio Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice J Immunol 162 1999 503 509
19. J. Pugin, C.C. Schurer-Maly, D. Leturcq, A. Moriarty, R.J. Ulevitch, and P.S. Tobias Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 Proc Natl Acad Sci U S A 90 1993 2744 2748
20. A. Haziot, G.W. Rong, J. Silver, and S.M. Goyert Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide J Immunol 151 1993 1500 1507
21. H. Loppnow, F. Stelter, and U. Schonbeck Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14 Infect Immun 63 1995 1020 1026
22. A. Haziot, G.W. Rong, X.Y. Lin, J. Silver, and S.M. Goyert Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide) J Immunol 154 1995 6529 6532
23. B. Yu, E. Hailman, and S.D. Wright Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids J Clin Invest 99 1997 315 324
24. W.A. Nockher, L. Bergmann, and J.E. Scherberich Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients Clin Exp Immunol 98 1994 369 374
25. E. Lien, P. Aukrust, A. Sundan, F. Muller, S.S. Froland, and T. Espevik Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events Blood 92 1998 2084 2092
26. C. Oesterreicher, F. Pfeffel, D. Petermann, and C. Muller Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease J Hepatol 23 1995 396 402
27. R. Urbaschek, R.S. McCuskey, and V. Rudi Endotoxin, endotoxin- neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease Alcohol Clin Exp Res 25 2001 261 268
28. C. Schafer, A. Parlesak, C. Schutt, J.C. Bode, and C. Bode Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease Alcohol Alcohol 37 2002 81 86
29. E. Jirillo, L. Amati, and L. Caradonna Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha Immunopharmacol Immunotoxicol 20 1998 1 14
30. S. Steyaert, P. Vanlandschoot, H. Van Vlierberghe, H. Diepolder, and G. Leroux-Roels Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients J Med Virol 71 2003 188 194
31. J.L. Heckel, E.P. Sandgren, J.L. Degen, R.D. Palmiter, and R.L. Brinster Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator Cell 62 1990 447 456
32. E.P. Sandgren, R.D. Palmiter, J.L. Heckel, C.C. Daugherty, R.L. Brinster, and J.L. Degen Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene Cell 66 1991 245 256
33. M. Dandri, M.R. Burda, and E. Torok Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus Hepatology 33 2001 981 988
34. D.F. Mercer, D.E. Schiller, and J.F. Elliott Hepatitis C virus replication in mice with chimeric human livers Nat Med 7 2001 927 933
35. P. Meuleman, L. Libbrecht, and R. De Vos Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera Hepatology 41 2005 847 856
36. P. Meuleman, P. Vanlandschoot, and G. Leroux-Roels A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice Biochem Biophys Res Commun 308 2003 375 378
37. K.G. Tournoy, S. Depraetere, P. Meuleman, G. Leroux-Roels, and R.A. Pauwels Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice Eur J Immunol 28 1998 3221 3230
38. R.A. Heijtink, J. Kruining, and P. Honkoop Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B J Med Virol 53 1997 282 287
39. F. Stelter, H. Loppnow, and R. Menzel Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide J Immunol 163 1999 6035 6044
40. F. Stelter, M. Pfister, and M. Bernheiden The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms Eur J Biochem 236 1996 457 464
41. Z. Pan, L. Zhou, C.J. Hetherington, and D.E. Zhang Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes J Biol Chem 275 2000 36430 36435
42. E. Louis, D. Franchimont, and A. Piron Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans Clin Exp Immunol 113 1998 401 406
43. Y. Choda, Y. Morimoto, and H. Miyaso Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor Eur J Gastroenterol Hepatol 16 2004 1017 1025
44. P. Carotenuto, D. van Riel, and A. Artsen Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B Antimicrob Agents Chemother 49 2005 590 599
45. M.O. Labeta, K. Vidal, and J.E. Nores Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14 J Exp Med 191 2000 1807 1812
46. A. Kaser, O. Ludwiczek, P. Waldenberger, W. Jaschke, W. Vogel, and H. Tilg Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting Liver 22 2002 380 387
47. A.S. Sozinov Systemic endotoxemia during chronic viral hepatitis Bull Exp Biol Med 133 2002 153 155
48. A. Parlesak, C. Schafer, T. Schutz, J.C. Bode, and C. Bode Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease J Hepatol 32 2000 742 747